Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Rheumatoid Arthritis

  Free Subscription


Articles published in Ann Rheum Dis

Retrieve available abstracts of 236 articles:
HTML format
Text format



Single Articles


    October 2019
  1. FORNARO M, Cacciapaglia F, Venerito V, Lopalco G, et al
    Response to: 'Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro et al' by Agca et al.
    Ann Rheum Dis. 2019 Oct 11. pii: annrheumdis-2019-216407.
    PubMed     Text format    


    September 2019
  2. LIOU YS, Lin TK, Chen HY, Jong GP, et al
    Medications associated with fracture risk in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2019 Sep 17. pii: annrheumdis-2019-216262.
    PubMed     Text format    


  3. SAFIRI S, Kolahi AA, Hoy D, Smith E, et al
    Global, regional and national burden of rheumatoid arthritis 1990-2017: a systematic analysis of the Global Burden of Disease study 2017.
    Ann Rheum Dis. 2019 Sep 11. pii: annrheumdis-2019-215920.
    PubMed     Text format     Abstract available


    August 2019
  4. KISSEL T, van Schie KA, Hafkenscheid L, Lundquist A, et al
    On the presence of HLA-SE alleles and ACPA-IgG variable domain glycosylation in the phase preceding the development of rheumatoid arthritis.
    Ann Rheum Dis. 2019 Aug 30. pii: annrheumdis-2019-215698.
    PubMed     Text format     Abstract available


  5. SONG G, Feng T, Zhao R, Lu Q, et al
    CD109 regulates the inflammatory response and is required for the pathogenesis of rheumatoid arthritis.
    Ann Rheum Dis. 2019 Aug 27. pii: annrheumdis-2019-215473.
    PubMed     Text format     Abstract available


  6. ALETAHA D, Maa JF, Chen S, Park SH, et al
    Effect of disease duration and prior disease-modifying antirheumatic drug use on treatment outcomes in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2019 Aug 21. pii: annrheumdis-2018-214918.
    PubMed     Text format     Abstract available


  7. PUTRIK P, Ramiro S, Guillemin F, Pentek M, et al
    Patients with rheumatoid arthritis facing sick leave or work disability meet varying regulations: a study among rheumatologists and patients from 44 European countries.
    Ann Rheum Dis. 2019 Aug 19. pii: annrheumdis-2019-215294.
    PubMed     Text format     Abstract available


  8. BOETERS DM, Burgers LE, Toes RE, van der Helm-van Mil A, et al
    Does immunological remission, defined as disappearance of autoantibodies, occur with current treatment strategies? A long-term follow-up study in rheumatoid arthritis patients who achieved sustained DMARD-free status.
    Ann Rheum Dis. 2019 Aug 14. pii: annrheumdis-2018-214868.
    PubMed     Text format     Abstract available


  9. AGCA R, Heslinga SC, Rollefstad S, Heslinga S, et al
    Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro et al.
    Ann Rheum Dis. 2019 Aug 14. pii: annrheumdis-2019-215748.
    PubMed     Text format    


  10. LIU YT, Tsou HK, Chiou JY, Wang YH, et al
    Association of human papillomavirus infection with risk for rheumatoid arthritis: a population-based cohort study.
    Ann Rheum Dis. 2019 Aug 14. pii: annrheumdis-2019-215931.
    PubMed     Text format    


  11. RODRIGUEZ-UBREVA J, de la Calle-Fabregat C, Li T, Ciudad L, et al
    Inflammatory cytokines shape a changing DNA methylome in monocytes mirroring disease activity in rheumatoid arthritis.
    Ann Rheum Dis. 2019 Aug 1. pii: annrheumdis-2019-215355.
    PubMed     Text format     Abstract available


    July 2019
  12. WALLACE BI, Wallace DM, Waljee AK, Clauw DJ, et al
    Evidence to support or guide glucocorticoid tapering in rheumatoid arthritis is lacking.
    Ann Rheum Dis. 2019 Jul 31. pii: annrheumdis-2019-216009.
    PubMed     Text format    


  13. FLEISCHMANN RM, Genovese MC, Enejosa JV, Mysler E, et al
    Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response.
    Ann Rheum Dis. 2019 Jul 30. pii: annrheumdis-2019-215764.
    PubMed     Text format     Abstract available


  14. TANAKA Y, Takeuchi T, Tanaka S, Kawakami A, et al
    Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to conventional DMARDs: a randomised, double-blind, placebo-controlled phase III trial (RAJ3).
    Ann Rheum Dis. 2019 Jul 26. pii: annrheumdis-2019-215163.
    PubMed     Text format     Abstract available


  15. TAKEUCHI T, Tanaka Y, Tanaka S, Kawakami A, et al
    Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in Japan.
    Ann Rheum Dis. 2019 Jul 26. pii: annrheumdis-2019-215164.
    PubMed     Text format     Abstract available


  16. HUMBY F, Lewis M, Townsend MJ, Pitzalis C, et al
    Response to 'Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients' by Humby et al.
    Ann Rheum Dis. 2019 Jul 13. pii: annrheumdis-2019-215903.
    PubMed     Text format    


  17. BUCH MH, Melville A, McGonagle DG
    Response to: 'Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients' by Humby et al.
    Ann Rheum Dis. 2019 Jul 13. pii: annrheumdis-2019-215881.
    PubMed     Text format    


  18. LAI SW, Kuo YH, Liao KF
    Association between proton pump inhibitors therapy and fracture risk in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2019 Jul 12. pii: annrheumdis-2019-215982.
    PubMed     Text format    


  19. XIE W, Xiao S, Zhang Z
    Response to: 'Impact of Janus kinase inhibitors on the risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials' by Lee and Song.
    Ann Rheum Dis. 2019 Jul 4. pii: annrheumdis-2019-215841.
    PubMed     Text format    


    June 2019
  20. POLLASTRO S, Klarenbeek PL, Doorenspleet ME, van Schaik BDC, et al
    Non-response to rituximab therapy in rheumatoid arthritis is associated with incomplete disruption of the B cell receptor repertoire.
    Ann Rheum Dis. 2019 Jun 19. pii: annrheumdis-2018-214898.
    PubMed     Text format     Abstract available


  21. HILLION J, Bellier A, Romand X, Fautrel B, et al
    Alcohol is not the missing link between Porphyromonas gingivalis-related periodontitis and radiological progression in early rheumatoid arthritis: comment on 'Porphyromonas gingivalis experimentally induces periodontitis and an anti-CCP2-associated ar
    Ann Rheum Dis. 2019 Jun 14. pii: annrheumdis-2019-215603.
    PubMed     Text format    


  22. VERHOEVEN MM, de Hair MJ, Tekstra J, Bijlsma JW, et al
    Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAME
    Ann Rheum Dis. 2019 Jun 13. pii: annrheumdis-2019-215304.
    PubMed     Text format     Abstract available


  23. LEE YH, Song GG
    Impact of Janus kinase inhibitors on the risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials.
    Ann Rheum Dis. 2019 Jun 11. pii: annrheumdis-2019-215815.
    PubMed     Text format    


  24. GLATT S, Taylor PC, McInnes IB, Schett G, et al
    Efficacy and safety of bimekizumab as add-on therapy for rheumatoid arthritis in patients with inadequate response to certolizumab pegol: a proof-of-concept study.
    Ann Rheum Dis. 2019 Jun 8. pii: annrheumdis-2018-214943.
    PubMed     Text format     Abstract available


  25. HAMMER HB, Michelsen B, Sexton J, Haugen IK, et al
    Swollen, but not tender joints, are independently associated with ultrasound synovitis: results from a longitudinal observational study of patients with established rheumatoid arthritis.
    Ann Rheum Dis. 2019 Jun 6. pii: annrheumdis-2019-215321.
    PubMed     Text format     Abstract available


  26. TAKESHITA M, Suzuki K, Kondo Y, Morita R, et al
    Multi-dimensional analysis identified rheumatoid arthritis-driving pathway in human T cell.
    Ann Rheum Dis. 2019 Jun 5. pii: annrheumdis-2018-214885.
    PubMed     Text format     Abstract available


    May 2019
  27. SUGIYAMA T
    Association of proton pump inhibitors with fracture risk in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2019 May 31. pii: annrheumdis-2019-215747.
    PubMed     Text format    


  28. FORNARO M, Cacciapaglia F, Venerito V, Lopalco G, et al
    Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients.
    Ann Rheum Dis. 2019 May 29. pii: annrheumdis-2019-215715.
    PubMed     Text format    


  29. INCE-ASKAN H, Mandaviya PR, Felix JF, Duijts L, et al
    Altered DNA methylation in children born to mothers with rheumatoid arthritis during pregnancy.
    Ann Rheum Dis. 2019 May 29. pii: annrheumdis-2018-214930.
    PubMed     Text format     Abstract available


  30. FINZEL S, Kraus S, Figueiredo CP, Regensburger A, et al
    Comparison of the effects of tocilizumab monotherapy and adalimumab in combination with methotrexate on bone erosion repair in rheumatoid arthritis.
    Ann Rheum Dis. 2019 May 29. pii: annrheumdis-2018-214894.
    PubMed     Text format     Abstract available


  31. MOTEGI T, Kochi Y, Matsuda K, Kubo M, et al
    Identification of rare coding variants in TYK2 protective for rheumatoid arthritis in the Japanese population and their effects on cytokine signalling.
    Ann Rheum Dis. 2019 May 22. pii: annrheumdis-2019-215062.
    PubMed     Text format     Abstract available


  32. MANKIA K, D'Agostino MA, Murillo-Gonzalez J, Grainger A, et al
    Response to: 'Interosseous tendon inflammation of rheumatoid arthritis: what's the real meaning?' by Deng et al.
    Ann Rheum Dis. 2019 May 17. pii: annrheumdis-2019-215611.
    PubMed     Text format    


  33. LIU X, Zhang W, Zhao M, Fu L, et al
    T cell receptor beta repertoires as novel diagnostic markers for systemic lupus erythematosus and rheumatoid arthritis.
    Ann Rheum Dis. 2019 May 17. pii: annrheumdis-2019-215442.
    PubMed     Text format     Abstract available


  34. DENG Z, Liu H, Lu W
    Interosseous tendon inflammation of rheumatoid arthritis: what's the real meaning?
    Ann Rheum Dis. 2019 May 17. pii: annrheumdis-2019-215559.
    PubMed     Text format    


  35. OZEN G, Pedro S, Wolfe F, Michaud K, et al
    Medications associated with fracture risk in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2019 May 15. pii: annrheumdis-2019-215328.
    PubMed     Text format     Abstract available


  36. XIE W, Huang Y, Xiao S, Sun X, et al
    Impact of Janus kinase inhibitors on risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials.
    Ann Rheum Dis. 2019 May 14. pii: annrheumdis-2018-214846.
    PubMed     Text format     Abstract available


  37. L'AMI MJ, Krieckaert CL, Nurmohamed MT, van Vollenhoven RF, et al
    Response to: 'Tapering without relapse in rheumatoid arthritis patients with high TNF blocker concentrations: data from the STRASS study' by Marotte et al.
    Ann Rheum Dis. 2019 May 9. pii: annrheumdis-2019-215609.
    PubMed     Text format    


  38. MAROTTE H, Rinaudo-Gaujous M, Petiet C, Fautrel B, et al
    Tapering without relapse in rheumatoid arthritis patients with high TNF blocker concentrations: data from STRASS study.
    Ann Rheum Dis. 2019 May 2. pii: annrheumdis-2019-215546.
    PubMed     Text format    


    April 2019
  39. TANAKA Y, Fautrel B, Keystone EC, Ortmann RA, et al
    Clinical outcomes in patients switched from adalimumab to baricitinib due to non-response and/or study design: phase III data in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2019 Apr 30. pii: annrheumdis-2018-214529.
    PubMed     Text format     Abstract available


  40. TAKEUCHI T, Tanaka Y, Soen S, Yamanaka H, et al
    Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled p
    Ann Rheum Dis. 2019 Apr 29. pii: annrheumdis-2018-214827.
    PubMed     Text format     Abstract available


  41. SPILIOPOULOU A, Colombo M, Plant D, Nair N, et al
    Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for CD40 and CD39.
    Ann Rheum Dis. 2019 Apr 29. pii: annrheumdis-2018-214877.
    PubMed     Text format     Abstract available


  42. SWEET K, Dasgupta B, de Vries D, Gourley I, et al
    Sirukumab and adalimumab reduce power Doppler ultrasound signal in patients with rheumatoid arthritis by 4 weeks in a phase III trial.
    Ann Rheum Dis. 2019 Apr 24. pii: annrheumdis-2019-215183.
    PubMed     Text format    


  43. VAN MULLIGEN E, de Jong PHP, Kuijper TM, van der Ven M, et al
    Gradual tapering TNF inhibitors versus conventional synthetic DMARDs after achieving controlled disease in patients with rheumatoid arthritis: first-year results of the randomised controlled TARA study.
    Ann Rheum Dis. 2019 Apr 6. pii: annrheumdis-2018-214970.
    PubMed     Text format     Abstract available


  44. GUO J, Zhang T, Cao H, Li X, et al
    Sequencing of the MHC region defines HLA-DQA1 as the major genetic risk for seropositive rheumatoid arthritis in Han Chinese population.
    Ann Rheum Dis. 2019 Apr 1. pii: annrheumdis-2018-214725.
    PubMed     Text format     Abstract available


    March 2019
  45. PARK JK, Choi Y, Winthrop KL, Song YW, et al
    Optimal time between the last methotrexate administration and seasonal influenza vaccination in rheumatoid arthritis: post hoc analysis of a randomised clinical trial.
    Ann Rheum Dis. 2019 Mar 23. pii: annrheumdis-2019-215187.
    PubMed     Text format    


  46. VISVANATHAN S, Daniluk S, Ptaszynski R, Muller-Ladner U, et al
    Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker parameters in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study.
    Ann Rheum Dis. 2019 Mar 22. pii: annrheumdis-2018-214729.
    PubMed     Text format     Abstract available



  47. Correction: Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss.
    Ann Rheum Dis. 2019 Mar 18. pii: annrheumdis-2015-208093.
    PubMed     Text format    


  48. HUMBY F, Lewis M, Ramamoorthi N, Hackney JA, et al
    Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients.
    Ann Rheum Dis. 2019 Mar 16. pii: annrheumdis-2018-214539.
    PubMed     Text format     Abstract available


  49. FENT G, Mankia K, Erhayiem B, Hunt L, et al
    First cardiovascular MRI study in individuals at risk of rheumatoid arthritis detects abnormal aortic stiffness suggesting an anti-citrullinated peptide antibody-mediated role for accelerated atherosclerosis.
    Ann Rheum Dis. 2019 Mar 9. pii: annrheumdis-2018-214975.
    PubMed     Text format    


  50. COMBE B, Balsa A, Sarzi-Puttini P, Tony HP, et al
    Efficacy and safety data based on historical or pre-existing conditions at baseline for patients with active rheumatoid arthritis who were treated with baricitinib.
    Ann Rheum Dis. 2019 Mar 6. pii: annrheumdis-2018-214261.
    PubMed     Text format    


    February 2019
  51. POPPELAARS PB, van Tuyl LHD, Boers M
    Normal mortality of the COBRA early rheumatoid arthritis trial cohort after 23 years of follow-up.
    Ann Rheum Dis. 2019 Feb 26. pii: annrheumdis-2018-214618.
    PubMed     Text format     Abstract available


  52. WESTERLIND H, Holmqvist M, Ljung L, Frisell T, et al
    Siblings of patients with rheumatoid arthritis are at increased risk of acute coronary syndrome.
    Ann Rheum Dis. 2019 Feb 20. pii: annrheumdis-2018-214828.
    PubMed     Text format     Abstract available


  53. ALPIZAR-RODRIGUEZ D, Lesker TR, Gronow A, Gilbert B, et al
    Prevotella copri in individuals at risk for rheumatoid arthritis.
    Ann Rheum Dis. 2019 Feb 13. pii: annrheumdis-2018-214514.
    PubMed     Text format     Abstract available


  54. CUTOLO M, Soldano S, Paolino S
    Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis.
    Ann Rheum Dis. 2019 Feb 1. pii: annrheumdis-2019-215063.
    PubMed     Text format    


    January 2019
  55. PAWAR A, Desai RJ, Solomon DH, Santiago Ortiz AJ, et al
    Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study.
    Ann Rheum Dis. 2019 Jan 24. pii: annrheumdis-2018-214367.
    PubMed     Text format     Abstract available


  56. NORGARD BM, Larsen MD, Friedman S, Knudsen T, et al
    Decreased chance of a live born child in women with rheumatoid arthritis after assisted reproduction treatment: a nationwide cohort study.
    Ann Rheum Dis. 2019 Jan 12. pii: annrheumdis-2018-214619.
    PubMed     Text format     Abstract available


  57. GRON KL, Arkema EV, Glintborg B, Mehnert F, et al
    Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden.
    Ann Rheum Dis. 2019 Jan 5. pii: annrheumdis-2018-214326.
    PubMed     Text format     Abstract available


  58. BURGGRAAF B, van Breukelen-van der Stoep DF, de Vries MA, Klop B, et al
    Effect of a treat-to-target intervention of cardiovascular risk factors on subclinical and clinical atherosclerosis in rheumatoid arthritis: a randomised clinical trial.
    Ann Rheum Dis. 2019 Jan 4. pii: annrheumdis-2018-214075.
    PubMed     Text format     Abstract available


  59. CHEN YM, Huang WN, Liao TL, Chen JP, et al
    Comparisons of hepatitis C viral replication in patients with rheumatoid arthritis receiving tocilizumab, abatacept and tofacitinib therapy.
    Ann Rheum Dis. 2019 Jan 3. pii: annrheumdis-2018-214400.
    PubMed     Text format    


    December 2018
  60. OKADA Y, Eyre S, Suzuki A, Kochi Y, et al
    Genetics of rheumatoid arthritis: 2018 status.
    Ann Rheum Dis. 2018 Dec 8. pii: annrheumdis-2018-213678.
    PubMed     Text format     Abstract available


  61. GERLAG DM, Safy M, Maijer KI, Tang MW, et al
    Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study.
    Ann Rheum Dis. 2018 Dec 1. pii: annrheumdis-2017-212763.
    PubMed     Text format     Abstract available


    October 2018
  62. BERGSTRA SA, Winchow LL, Murphy E, Chopra A, et al
    How to treat patients with rheumatoid arthritis when methotrexate has failed? The use of a multiple propensity score to adjust for confounding by indication in observational studies.
    Ann Rheum Dis. 2018 Oct 16. pii: annrheumdis-2018-213731.
    PubMed     Text format     Abstract available


  63. SINGH JA
    Tapering Janus kinase inhibitors in rheumatoid arthritis with low disease activity or remission: reality or dream?
    Ann Rheum Dis. 2018 Oct 9. pii: annrheumdis-2018-213694.
    PubMed     Text format    


  64. ZHU H, Wu LF, Mo XB, Lu X, et al
    Rheumatoid arthritis-associated DNA methylation sites in peripheral blood mononuclear cells.
    Ann Rheum Dis. 2018 Oct 8. pii: annrheumdis-2018-213970.
    PubMed     Text format     Abstract available


  65. PARK JK, Lee YJ, Bitoun S, Winthrop KL, et al
    Interaction between B-cell activation factor and methotrexate impacts immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2018 Oct 8. pii: annrheumdis-2018-214025.
    PubMed     Text format    


  66. MARTINEZ-PRAT L, Lucia D, Ibarra C, Mahler M, et al
    Antibodies targeting protein-arginine deiminase 4 (PAD4) demonstrate diagnostic value in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Oct 8. pii: annrheumdis-2018-213818.
    PubMed     Text format    


    September 2018
  67. DIEKHOFF T, Ulas ST, Poddubnyy D, Schneider U, et al
    Ultra-low-dose CT detects synovitis in patients with suspected rheumatoid arthritis.
    Ann Rheum Dis. 2018 Sep 29. pii: annrheumdis-2018-213904.
    PubMed     Text format     Abstract available


  68. TSUJI H, Ikari K, Ohmura K, Yano K, et al
    Significant joint-destructive association of HLA-DRB1*04:05 independent of DAS28 in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Sep 19. pii: annrheumdis-2018-214022.
    PubMed     Text format    


  69. TAKEUCHI T, Genovese MC, Haraoui B, Li Z, et al
    Dose reduction of baricitinib in patients with rheumatoid arthritis achieving sustained disease control: results of a prospective study.
    Ann Rheum Dis. 2018 Sep 7. pii: annrheumdis-2018-213271.
    PubMed     Text format     Abstract available


  70. ROODENRIJS NMT, de Hair MJH, van der Goes MC, Jacobs JWG, et al
    Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey.
    Ann Rheum Dis. 2018 Sep 7. pii: annrheumdis-2018-213687.
    PubMed     Text format     Abstract available


    August 2018
  71. TEITSMA XM, Jacobs JWG, de Jong PHP, Hazes JMW, et al
    Adding baseline protein biomarkers to clinical predictors does not enhance prediction of treatment response to a methotrexate strategy in early rheumatoid arthritis.
    Ann Rheum Dis. 2018 Aug 29. pii: annrheumdis-2018-213767.
    PubMed     Text format    


  72. RIVELLESE F, Mauro D, Nerviani A, Pagani S, et al
    Mast cells in early rheumatoid arthritis associate with disease severity and support B cell autoantibody production.
    Ann Rheum Dis. 2018 Aug 20. pii: annrheumdis-2018-213418.
    PubMed     Text format     Abstract available


  73. FERREIRA RJO, Ndosi M, de Wit M, Santos EJF, et al
    Dual target strategy: a proposal to mitigate the risk of overtreatment and enhance patient satisfaction in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Aug 20. pii: annrheumdis-2018-214199.
    PubMed     Text format    


  74. VAN DELFT MAM, van der Woude D, Toes REM, Trouw LA, et al
    Secretory form of rheumatoid arthritis-associated autoantibodies in serum are mainly of the IgM isotype, suggesting a continuous reactivation of autoantibody responses at mucosal surfaces.
    Ann Rheum Dis. 2018 Aug 14. pii: annrheumdis-2018-213724.
    PubMed     Text format    


  75. LANDEWE RBM
    Response to: 'Early identification of rheumatoid arthritis; the risk of overtreatment in perspective' by Landewe.
    Ann Rheum Dis. 2018 Aug 10. pii: annrheumdis-2018-214172.
    PubMed     Text format    


  76. VAN DER HELM-VAN MIL A
    Early identification of rheumatoid arthritis: the risk of overtreatment in perspective.
    Ann Rheum Dis. 2018 Aug 10. pii: annrheumdis-2018-214156.
    PubMed     Text format    


  77. SMOLEN JS, van Vollenhoven RF, Florentinus S, Chen S, et al
    Predictors of disease activity and structural progression after treatment with adalimumab plus methotrexate or continued methotrexate monotherapy in patients with early rheumatoid arthritis and suboptimal response to methotrexate.
    Ann Rheum Dis. 2018 Aug 3. pii: annrheumdis-2018-213502.
    PubMed     Text format     Abstract available


    July 2018
  78. BUSTAMANTE MF, Oliveira PG, Garcia-Carbonell R, Croft AP, et al
    Hexokinase 2 as a novel selective metabolic target for rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jul 30. pii: annrheumdis-2018-213103.
    PubMed     Text format     Abstract available


  79. JIN S, Chen H, Li Y, Zhong H, et al
    Maresin 1 improves the Treg/Th17 imbalance in rheumatoid arthritis through miR-21.
    Ann Rheum Dis. 2018 Jul 25. pii: annrheumdis-2018-213511.
    PubMed     Text format     Abstract available


  80. BITOUN S, Miceli-Richard C, Verstuyft C, Juge PA, et al
    Frequency of tumour necrosis factor alpha receptor superfamily 1A multiple sclerosis-associated variants in patients with rheumatoid arthritis with anti-tumour necrosis factor therapy-related demyelinating complications.
    Ann Rheum Dis. 2018 Jul 20. pii: annrheumdis-2018-213183.
    PubMed     Text format    


  81. JANS L, De Kock I, Herregods N, Verstraete KL, et al
    Response to: 'The use of dual-energy CT to detect and depict bone marrow oedema in rheumatoid arthritis: is it ready to substitute MRI?' by Wu et al.
    Ann Rheum Dis. 2018 Jul 12. pii: annrheumdis-2018-213960.
    PubMed     Text format    


  82. WU H, Zhang G, Huang X, Liang C, et al
    Use of dual-energy CT to detect and depict bone marrow oedema in rheumatoid arthritis: is it ready to substitute MRI?
    Ann Rheum Dis. 2018 Jul 12. pii: annrheumdis-2018-213892.
    PubMed     Text format    


  83. LEE JY, Kang MJ, Choi JY, Park JS, et al
    Apolipoprotein B binds to enolase-1 and aggravates inflammation in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jul 11. pii: annrheumdis-2018-213444.
    PubMed     Text format     Abstract available


  84. NEUMANN E, Schwarz MC, Hasseli R, Hulser ML, et al
    Tetraspanin CD82 affects migration, attachment and invasion of rheumatoid arthritis synovial fibroblasts.
    Ann Rheum Dis. 2018 Jul 6. pii: annrheumdis-2018-212954.
    PubMed     Text format     Abstract available


  85. KEARSLEY-FLEET L, Davies R, De Cock D, Watson KD, et al
    Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
    Ann Rheum Dis. 2018 Jul 6. pii: annrheumdis-2018-213378.
    PubMed     Text format     Abstract available


  86. DIAZ-GALLO LM, Ramskold D, Shchetynsky K, Folkersen L, et al
    Systematic approach demonstrates enrichment of multiple interactions between non-HLA risk variants and HLA-DRB1 risk alleles in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jul 2. pii: annrheumdis-2018-213412.
    PubMed     Text format     Abstract available


    June 2018
  87. PAULSHUS SUNDLISAETER N, Aga AB, Olsen IC, Hammer HB, et al
    Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: associations to future good radiographic and physical outcomes.
    Ann Rheum Dis. 2018 Jun 22. pii: annrheumdis-2017-212830.
    PubMed     Text format     Abstract available


  88. SOHRABIAN A, Mathsson-Alm L, Hansson M, Knight A, et al
    Number of individual ACPA reactivities in synovial fluid immune complexes, but not serum anti-CCP2 levels, associate with inflammation and joint destruction in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jun 12. pii: annrheumdis-2017-212627.
    PubMed     Text format     Abstract available


  89. FILIPPOU G, Sakellariou G, Scire CA, Carrara G, et al
    The predictive role of ultrasound-detected tenosynovitis and joint synovitis for flare in patients with rheumatoid arthritis in stable remission. Results of an Italian multicentre study of the Italian Society for Rheumatology Group for Ultrasound: the
    Ann Rheum Dis. 2018 Jun 9. pii: annrheumdis-2018-213217.
    PubMed     Text format     Abstract available


  90. HILLIQUIN S, Hugues B, Mitrovic S, Gossec L, et al
    Ability of disease-modifying antirheumatic drugs to prevent or delay rheumatoid arthritis onset: a systematic literature review and meta-analysis.
    Ann Rheum Dis. 2018 Jun 8. pii: annrheumdis-2017-212612.
    PubMed     Text format     Abstract available


  91. MICHELSEN B, Uhlig T, Sexton J, van der Heijde D, et al
    Health-related quality of life in patients with psoriatic and rheumatoid arthritis: data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls.
    Ann Rheum Dis. 2018 Jun 6. pii: annrheumdis-2018-213286.
    PubMed     Text format     Abstract available


    May 2018
  92. KANEKO Y, Kato M, Tanaka Y, Inoo M, et al
    Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SUR
    Ann Rheum Dis. 2018 May 31. pii: annrheumdis-2018-213416.
    PubMed     Text format     Abstract available


  93. TEITSMA XM, Jacobs JWG, Welsing PMJ, de Jong PHP, et al
    Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictors.
    Ann Rheum Dis. 2018 May 14. pii: annrheumdis-2018-213035.
    PubMed     Text format     Abstract available


  94. LAUPER K, Nordstrom DC, Pavelka K, Hernandez MV, et al
    Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modi
    Ann Rheum Dis. 2018 May 5. pii: annrheumdis-2017-212845.
    PubMed     Text format     Abstract available


  95. HEDSTROM AK, Klareskog L, Alfredsson L
    Exposure to passive smoking and rheumatoid arthritis risk: results from the Swedish EIRA study.
    Ann Rheum Dis. 2018 May 3. pii: annrheumdis-2018-212973.
    PubMed     Text format     Abstract available


  96. MUNICIO C, Dominguez-Soto A, Fuentelsaz-Romero S, Lamana A, et al
    Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism.
    Ann Rheum Dis. 2018;77:752-759.
    PubMed     Text format     Abstract available


  97. FRISELL T, Baecklund E, Bengtsson K, Di Giuseppe D, et al
    Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics.
    Ann Rheum Dis. 2018;77:650-657.
    PubMed     Text format     Abstract available


  98. PISETSKY DS
    How the gut inflames the joints.
    Ann Rheum Dis. 2018;77:634-635.
    PubMed     Text format    


  99. WINTHROP KL, Baddley JW
    Pneumocystis and glucocorticoid use: to prophylax or not to prophylax (and when?); that is the question.
    Ann Rheum Dis. 2018;77:631-633.
    PubMed     Text format    


    April 2018
  100. BOER AC, Boeters DM, van der Helm-van Mil AHM
    The use of MRI-detected synovitis to determine the number of involved joints for the 2010 ACR/EULAR classification criteria for Rheumatoid Arthritis - is it of additional benefit?
    Ann Rheum Dis. 2018 Apr 20. pii: annrheumdis-2018-213143.
    PubMed     Text format     Abstract available


  101. CHEN YM, Liao TL, Chen HH, Chen DY, et al
    Three months of once-weekly isoniazid plus rifapentine (3HP) in treating latent tuberculosis infection is feasible in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2018 Apr 19. pii: annrheumdis-2018-213097.
    PubMed     Text format    


  102. SANTOS EJF, Duarte C, Ferreira RJO, Pinto AM, et al
    Determinants of happiness and quality of life in patients with rheumatoid arthritis: a structural equation modelling approach.
    Ann Rheum Dis. 2018 Apr 6. pii: annrheumdis-2017-212934.
    PubMed     Text format     Abstract available


  103. BONDT A, Hafkenscheid L, Falck D, Kuijper TM, et al
    ACPA IgG galactosylation associates with disease activity in pregnant patients with rheumatoid arthritis.
    Ann Rheum Dis. 2018 Apr 3. pii: annrheumdis-2018-212946.
    PubMed     Text format     Abstract available


  104. MOSSEL E, Arends S, van Nimwegen JF, Delli K, et al
    Scoring hypoechogenic areas in one parotid and one submandibular gland increases feasibility of ultrasound in primary Sjogren's syndrome.
    Ann Rheum Dis. 2018;77:556-562.
    PubMed     Text format     Abstract available


  105. DAIEN CI, Tubery A, Cailar GD, Mura T, et al
    Application of the 2015/2016 EULAR recommendations for cardiovascular risk in daily practice: data from an observational study.
    Ann Rheum Dis. 2018;77:625-626.
    PubMed     Text format    


  106. MULLEMAN D, Balsa A
    Adalimumab concentration-based tapering strategy: as good as the recommended dosage.
    Ann Rheum Dis. 2018;77:473-475.
    PubMed     Text format    


    March 2018
  107. RUTHERFORD AI, Subesinghe S, Hyrich KL, Galloway JB, et al
    Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatolgy Biologics Register for Rheumatoid Arthritis.
    Ann Rheum Dis. 2018 Mar 28. pii: annrheumdis-2017-212825.
    PubMed     Text format     Abstract available


  108. BUCH MH
    Defining refractory rheumatoid arthritis.
    Ann Rheum Dis. 2018 Mar 27. pii: annrheumdis-2017-212862.
    PubMed     Text format     Abstract available


  109. PARK JK, Lee YJ, Shin K, Ha YJ, et al
    Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial.
    Ann Rheum Dis. 2018 Mar 23. pii: annrheumdis-2018-213222.
    PubMed     Text format     Abstract available


  110. COHEN SB, Alonso-Ruiz A, Klimiuk PA, Lee EC, et al
    Similar efficacy, safety and immunogenicity of adalimumab biosimilar BI 695501 and Humira reference product in patients with moderately to severely active rheumatoid arthritis: results from the phase III randomised VOLTAIRE-RA equivalence study.
    Ann Rheum Dis. 2018 Mar 7. pii: annrheumdis-2017-212245.
    PubMed     Text format     Abstract available


  111. LEONARD D, Svenungsson E, Dahlqvist J, Alexsson A, et al
    Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis.
    Ann Rheum Dis. 2018 Mar 7. pii: annrheumdis-2017-212614.
    PubMed     Text format     Abstract available


  112. GADEHOLT O
    Forward to the past: ultrasound might be necessary in some patients with rheumatoid arthritis.
    Ann Rheum Dis. 2018 Mar 6. pii: annrheumdis-2018-213278.
    PubMed     Text format    


  113. JANS L, De Kock I, Herregods N, Verstraete K, et al
    Dual-energy CT: a new imaging modality for bone marrow oedema in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Mar 1. pii: annrheumdis-2018-213152.
    PubMed     Text format    


  114. JUST SA, Rostgaard K, Titlestad K, Edgren G, et al
    Transmission of rheumatoid arthritis through blood transfusion: a retrospective cohort study.
    Ann Rheum Dis. 2018 Mar 1. pii: annrheumdis-2017-212844.
    PubMed     Text format    


  115. FISHER BA, Everett CC, Rout J, O'Dwyer JL, et al
    Effect of rituximab on a salivary gland ultrasound score in primary Sjogren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy.
    Ann Rheum Dis. 2018;77:412-416.
    PubMed     Text format     Abstract available


    February 2018
  116. TAYLOR PC, Schiff MH, Wang Q, Jiang Y, et al
    Efficacy and safety of monotherapy with sirukumab compared with adalimumab monotherapy in biologic-naive patients with active rheumatoid arthritis (SIRROUND-H): a randomised, double-blind, parallel-group, multinational, 52-week, phase 3 study.
    Ann Rheum Dis. 2018 Feb 26. pii: annrheumdis-2017-212496.
    PubMed     Text format     Abstract available


  117. STEMMLER F, Simon D, Liphardt AM, Englbrecht M, et al
    Biomechanical properties of bone are impaired in patients with ACPA-positive rheumatoid arthritis and associated with the occurrence of fractures.
    Ann Rheum Dis. 2018 Feb 23. pii: annrheumdis-2017-212404.
    PubMed     Text format     Abstract available


  118. LI HZ, Xu XH, Lin N, Lu HD, et al
    Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis.
    Ann Rheum Dis. 2018 Feb 16. pii: annrheumdis-2018-213157.
    PubMed     Text format    


  119. DE PABLO P, Romaguera D, Fisk HL, Calder PC, et al
    High erythrocyte levels of the n-6 polyunsaturated fatty acid linoleic acid are associated with lower risk of subsequent rheumatoid arthritis in a southern European nested case-control study.
    Ann Rheum Dis. 2018 Feb 7. pii: annrheumdis-2017-212274.
    PubMed     Text format     Abstract available


  120. ZEISBRICH M, Yanes RE, Zhang H, Watanabe R, et al
    Hypermetabolic macrophages in rheumatoid arthritis and coronary artery disease due to glycogen synthase kinase 3b inactivation.
    Ann Rheum Dis. 2018 Feb 3. pii: annrheumdis-2017-212647.
    PubMed     Text format     Abstract available


    January 2018
  121. VAN HOOVELS L, Jacobs J, Vander Cruyssen B, Van den Bremt S, et al
    Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR/EULAR classification of rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jan 23. pii: annrheumdis-2017-212365.
    PubMed     Text format     Abstract available


  122. VAN VOLLENHOVEN RF, Keystone EC, Strand V, Pacheco-Tena C, et al
    Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial.
    Ann Rheum Dis. 2018 Jan 17. pii: annrheumdis-2017-212478.
    PubMed     Text format     Abstract available


  123. CHEVREAU M, Paclet MH, Romand X, Quesada JL, et al
    Calprotectin is not independent from baseline erosion in predicting radiological progression in early rheumatoid arthritis. Comment on 'Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis' by Jonsson et al.
    Ann Rheum Dis. 2018 Jan 10. pii: annrheumdis-2017-212816.
    PubMed     Text format    


  124. BOER AC, Huizinga TWJ, van der Helm-van Mil AHM
    Depression and anxiety associate with less remission after 1 year in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jan 8. pii: annrheumdis-2017-212867.
    PubMed     Text format    


  125. RADNER H, Chatzidionysiou K, Nikiphorou E, Gossec L, et al
    2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jan 4. pii: annrheumdis-2017-212256.
    PubMed     Text format     Abstract available


  126. AKDEMIR G, Heimans L, Bergstra SA, Goekoop RJ, et al
    Clinical and radiological outcomes of 5-year drug-free remission-steered treatment in patients with early arthritis: IMPROVED study.
    Ann Rheum Dis. 2018;77:111-118.
    PubMed     Text format     Abstract available


  127. SCHONAU V, Vogel K, Englbrecht M, Wacker J, et al
    The value of (18)F-FDG-PET/CT in identifying the cause of fever of unknown origin (FUO) and inflammation of unknown origin (IUO): data from a prospective study.
    Ann Rheum Dis. 2018;77:70-77.
    PubMed     Text format     Abstract available


  128. WANG-RENAULT SF, Boudaoud S, Nocturne G, Roche E, et al
    Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sjogren's syndrome.
    Ann Rheum Dis. 2018;77:133-140.
    PubMed     Text format     Abstract available


    December 2017
  129. CURTIS JR, Xie F, Chen L, Saag KG, et al
    Biomarker-related risk for myocardial infarction and serious infections in patients with rheumatoid arthritis: a population-based study.
    Ann Rheum Dis. 2017 Dec 21. pii: annrheumdis-2017-211727.
    PubMed     Text format     Abstract available


  130. MATSUNO H, Tomomitsu M, Hagino A, Shin S, et al
    Phase III, multicentre, double-blind, randomised, parallel-group study to evaluate the similarities between LBEC0101 and etanercept reference product in terms of efficacy and safety in patients with active rheumatoid arthritis inadequately responding
    Ann Rheum Dis. 2017 Dec 19. pii: annrheumdis-2017-212172.
    PubMed     Text format     Abstract available


  131. FRAENKEL L, Nowell WB, Michel G, Wiedmeyer C, et al
    Preference phenotypes to facilitate shared decision-making in rheumatoid arthritis.
    Ann Rheum Dis. 2017 Dec 15. pii: annrheumdis-2017-212407.
    PubMed     Text format     Abstract available


  132. CORDTZ RL, Hawley S, Prieto-Alhambra D, Hojgaard P, et al
    Incidence of hip and knee replacement in patients with rheumatoid arthritis following the introduction of biological DMARDs: an interrupted time-series analysis using nationwide Danish healthcare registers.
    Ann Rheum Dis. 2017 Dec 15. pii: annrheumdis-2017-212424.
    PubMed     Text format     Abstract available


  133. DREYER L, Cordtz RL, Hansen IMJ, Kristensen LE, et al
    Risk of second malignant neoplasm and mortality in patients with rheumatoid arthritis treated with biological DMARDs: a Danish population-based cohort study.
    Ann Rheum Dis. 2017 Dec 7. pii: annrheumdis-2017-212086.
    PubMed     Text format     Abstract available


  134. GAUJOUX-VIALA C, Rincheval N, Dougados M, Combe B, et al
    Optimal methotrexate dose is associated with better clinical outcomes than non-optimal dose in daily practice: results from the ESPOIR early arthritis cohort.
    Ann Rheum Dis. 2017;76:2054-2060.
    PubMed     Text format     Abstract available


  135. TSUBOI H, Hagiwara S, Asashima H, Takahashi H, et al
    Comparison of performance of the 2016 ACR-EULAR classification criteria for primary Sjogren's syndrome with other sets of criteria in Japanese patients.
    Ann Rheum Dis. 2017;76:1980-1985.
    PubMed     Text format     Abstract available


    November 2017
  136. SMILJANOVIC B, Radzikowska A, Kuca-Warnawin E, Kurowska W, et al
    Monocyte alterations in rheumatoid arthritis are dominated by preterm release from bone marrow and prominent triggering in the joint.
    Ann Rheum Dis. 2017 Nov 30. pii: annrheumdis-2017-211649.
    PubMed     Text format     Abstract available


  137. HENAUX S, Ruyssen-Witrand A, Cantagrel A, Barnetche T, et al
    Risk of losing remission, low disease activity or radiographic progression in case of bDMARD discontinuation or tapering in rheumatoid arthritis: systematic analysis of the literature and meta-analysis.
    Ann Rheum Dis. 2017 Nov 29. pii: annrheumdis-2017-212423.
    PubMed     Text format     Abstract available


  138. WEIJERS JM, Rongen-van Dartel SAA, Hoevenaars DMGMF, Rubens M, et al
    Implementation of the EULAR cardiovascular risk management guideline in patients with rheumatoid arthritis: results of a successful collaboration between primary and secondary care.
    Ann Rheum Dis. 2017 Nov 22. pii: annrheumdis-2017-212392.
    PubMed     Text format     Abstract available


  139. MO WX, Yin SS, Chen H, Zhang X, et al
    Amino-bisphosphonates, gammadeltaT cells, and their roles in Rheumatoid Arthritis.
    Ann Rheum Dis. 2017 Nov 17. pii: annrheumdis-2017-212569.
    PubMed     Text format    


  140. KAVANAUGH A, van Vollenhoven R, Fleischmann RM, Emery P, et al
    Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis.
    Ann Rheum Dis. 2017 Nov 16. pii: annrheumdis-2017-211871.
    PubMed     Text format     Abstract available


  141. L'AMI MJ, Krieckaert CLM, Nurmohamed MT, van Vollenhoven RF, et al
    Response to: Comment on l'Ami et al titled 'Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial' by den Broeder et al.
    Ann Rheum Dis. 2017 Nov 13. pii: annrheumdis-2017-212602.
    PubMed     Text format    


  142. GOSSEC L, Chauvin P, Saraux A, Hudry C, et al
    Development and psychometric validation of a patient-reported outcome measure to assess fears in rheumatoid arthritis and axial spondyloarthritis: the Fear Assessment in Inflammatory Rheumatic diseases (FAIR) questionnaire.
    Ann Rheum Dis. 2017 Nov 4. pii: annrheumdis-2017-212000.
    PubMed     Text format     Abstract available


  143. CORDTZ RL, Zobbe K, Hojgaard P, Kristensen LE, et al
    Predictors of revision, prosthetic joint infection and mortality following total hip or total knee arthroplasty in patients with rheumatoid arthritis: a nationwide cohort study using Danish healthcare registers.
    Ann Rheum Dis. 2017 Nov 2. pii: annrheumdis-2017-212339.
    PubMed     Text format     Abstract available


  144. MOSSEL E, Delli K, van Nimwegen JF, Stel AJ, et al
    Ultrasonography of major salivary glands compared with parotid and labial gland biopsy and classification criteria in patients with clinically suspected primary Sjogren's syndrome.
    Ann Rheum Dis. 2017;76:1883-1889.
    PubMed     Text format     Abstract available


  145. DEN BROEDER AA, van den Bemt BJF
    Comment on l'Ami et al titled 'Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial'.
    Ann Rheum Dis. 2017 Nov 1. pii: annrheumdis-2017-212579.
    PubMed     Text format    


    October 2017
  146. ROSSINI M, Adami G, Viapiana O, Idolazzi L, et al
    Rheumatoid arthritis, gammadelta T cells and bisphosphonates.
    Ann Rheum Dis. 2017 Oct 26. pii: annrheumdis-2017-212510.
    PubMed     Text format    


  147. SHI J, Darrah E, Sims GP, Mustelin T, et al
    Affinity maturation shapes the function of agonistic antibodies to peptidylarginine deiminase type 4 in rheumatoid arthritis.
    Ann Rheum Dis. 2017 Oct 25. pii: annrheumdis-2017-211489.
    PubMed     Text format     Abstract available


  148. RONNELID J, Hansson M, Mathsson-Alm L, Cornillet M, et al
    Anticitrullinated protein/peptide antibody multiplexing defines an extended group of ACPA-positive rheumatoid arthritis patients with distinct genetic and environmental determinants.
    Ann Rheum Dis. 2017 Oct 25. pii: annrheumdis-2017-211782.
    PubMed     Text format     Abstract available


  149. SMOLEN JS, Choe JY, Prodanovic N, Niebrzydowski J, et al
    Safety, immunogenicity and efficacy after switching from reference infliximab to biosimilar SB2 compared with continuing reference infliximab and SB2 in patients with rheumatoid arthritis: results of a randomised, double-blind, phase III transition st
    Ann Rheum Dis. 2017 Oct 17. pii: annrheumdis-2017-211741.
    PubMed     Text format     Abstract available


  150. ERIKSSON K, Nise L, Alfredsson L, Catrina AI, et al
    Seropositivity combined with smoking is associated with increased prevalence of periodontitis in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2017 Oct 6. pii: annrheumdis-2017-212091.
    PubMed     Text format    


  151. BRAUNER S, Folkersen L, Kvarnstrom M, Meisgen S, et al
    H1N1 vaccination in Sjogren's syndrome triggers polyclonal B cell activation and promotes autoantibody production.
    Ann Rheum Dis. 2017;76:1755-1763.
    PubMed     Text format     Abstract available


  152. HAACKE EA, van der Vegt B, Vissink A, Spijkervet FKL, et al
    Germinal centres in diagnostic labial gland biopsies of patients with primary Sjogren's syndrome are not predictive for parotid MALT lymphoma development.
    Ann Rheum Dis. 2017;76:1781-1784.
    PubMed     Text format     Abstract available


  153. BURGERS LE, van Steenbergen HW, Ten Brinck RM, Huizinga TW, et al
    Differences in the symptomatic phase preceding ACPA-positive and ACPA-negative RA: a longitudinal study in arthralgia during progression to clinical arthritis.
    Ann Rheum Dis. 2017;76:1751-1754.
    PubMed     Text format     Abstract available


    September 2017
  154. HOLMQVIST M, Ljung L, Askling J
    Mortality following new-onset Rheumatoid Arthritis: has modern Rheumatology had an impact?
    Ann Rheum Dis. 2017 Sep 26. pii: annrheumdis-2017-212131.
    PubMed     Text format     Abstract available


  155. REMPENAULT C, Combe B, Barnetche T, Gaujoux-Viala C, et al
    Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis.
    Ann Rheum Dis. 2017 Sep 25. pii: annrheumdis-2017-211836.
    PubMed     Text format     Abstract available


  156. MORITA T, Fujimoto K, Shima Y, Ogata A, et al
    Minimal neonatal transfer of certolizumab pegol in a Japanese patient with rheumatoid arthritis.
    Ann Rheum Dis. 2017 Sep 22. pii: annrheumdis-2017-212366.
    PubMed     Text format    


  157. L'AMI MJ, Krieckaert CL, Nurmohamed MT, van Vollenhoven RF, et al
    Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial.
    Ann Rheum Dis. 2017 Sep 22. pii: annrheumdis-2017-211781.
    PubMed     Text format     Abstract available


  158. ROBERTSON J, Porter D, Sattar N, Packard CJ, et al
    Interleukin-6 blockade raises LDL via reduced catabolism rather than via increased synthesis: a cytokine-specific mechanism for cholesterol changes in rheumatoid arthritis.
    Ann Rheum Dis. 2017 Sep 15. pii: annrheumdis-2017-211708.
    PubMed     Text format     Abstract available


  159. ZENG P, Chen Z, Klareskog L, Alfredsson L, et al
    Amount of smoking, duration of smoking cessation and their interaction with silica exposure in the risk of rheumatoid arthritis among males: results from the Swedish Epidemiological Investigation of Rheumatoid Arthritis (EIRA) study.
    Ann Rheum Dis. 2017 Sep 15. pii: annrheumdis-2017-212145.
    PubMed     Text format    


  160. CROWSON CS, Rollefstad S, Ikdahl E, Kitas GD, et al
    Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2017 Sep 6. pii: annrheumdis-2017-211735.
    PubMed     Text format     Abstract available


  161. MO WX, Yin SS, Chen H, Zhou C, et al
    Chemotaxis of Vdelta2 T cells to the joints contributes to the pathogenesis of rheumatoid arthritis.
    Ann Rheum Dis. 2017 Sep 2. pii: annrheumdis-2016-211069.
    PubMed     Text format     Abstract available


  162. BREBAN M, Tap J, Leboime A, Said-Nahal R, et al
    Faecal microbiota study reveals specific dysbiosis in spondyloarthritis.
    Ann Rheum Dis. 2017;76:1614-1622.
    PubMed     Text format     Abstract available


    August 2017
  163. TAKEUCHI T, Thorne C, Karpouzas G, Sheng S, et al
    Sirukumab for rheumatoid arthritis: the phase III SIRROUND-D study.
    Ann Rheum Dis. 2017 Aug 30. pii: annrheumdis-2017-211328.
    PubMed     Text format     Abstract available


  164. FILER A, Ward LSC, Kemble S, Davies CS, et al
    Identification of a transitional fibroblast function in very early rheumatoid arthritis.
    Ann Rheum Dis. 2017 Aug 28. pii: annrheumdis-2017-211286.
    PubMed     Text format     Abstract available


  165. OIWA H
    Concerns on glucocorticoid use for Japanese patients with established rheumatoid arthritis.
    Ann Rheum Dis. 2017 Aug 22. pii: annrheumdis-2017-212206.
    PubMed     Text format    


  166. ORYOJI K, Yoshida K, Kashiwado Y, Tanaka K, et al
    Shared epitope positivity is related to efficacy of abatacept in rheumatoid arthritis.
    Ann Rheum Dis. 2017 Aug 22. pii: annrheumdis-2017-211430.
    PubMed     Text format    


  167. OLSEN CM, Green AC
    Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: an updated meta-analysis.
    Ann Rheum Dis. 2017 Aug 22. pii: annrheumdis-2017-212205.
    PubMed     Text format    


  168. MANTEL A, Holmqvist M, Jernberg T, Wallberg-Jonsson S, et al
    Long-term outcomes and secondary prevention after acute coronary events in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2017 Aug 20. pii: annrheumdis-2017-211608.
    PubMed     Text format     Abstract available


  169. MERCER LK, Regierer AC, Mariette X, Dixon WG, et al
    Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project.
    Ann Rheum Dis. 2017 Aug 19. pii: annrheumdis-2017-211623.
    PubMed     Text format     Abstract available


  170. ORELLANA C, Saevarsdottir S, Klareskog L, Karlson EW, et al
    Oral contraceptives, breastfeeding and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study.
    Ann Rheum Dis. 2017 Aug 17. pii: annrheumdis-2017-211620.
    PubMed     Text format     Abstract available


  171. JONSSON MK, Sundlisaeter NP, Nordal HH, Hammer HB, et al
    Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis.
    Ann Rheum Dis. 2017 Aug 16. pii: annrheumdis-2017-211695.
    PubMed     Text format     Abstract available


  172. SCALLY SW, Law SC, Ting YT, Heemst JV, et al
    Molecular basis for increased susceptibility of Indigenous North Americans to seropositive rheumatoid arthritis.
    Ann Rheum Dis. 2017 Aug 11. pii: annrheumdis-2017-211300.
    PubMed     Text format     Abstract available


  173. BRINKMANN GH, Norli ES, Boyesen P, Heijde DVH, et al
    Role of erosions typical of rheumatoid arthritis in the 2010 ACR/EULAR rheumatoid arthritis classification criteria: results from a very early arthritis cohort.
    Ann Rheum Dis. 2017 Aug 10. pii: annrheumdis-2017-211350.
    PubMed     Text format     Abstract available


  174. KEYSTONE EC, Taylor PC, Tanaka Y, Gaich C, et al
    Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study.
    Ann Rheum Dis. 2017 Aug 10. pii: annrheumdis-2017-211259.
    PubMed     Text format     Abstract available


  175. EMERY P, Vencovsky J, Sylwestrzak A, Leszczynski P, et al
    Long-term efficacy and safety in patients with rheumatoid arthritis continuing on SB4 or switching from reference etanercept to SB4.
    Ann Rheum Dis. 2017 Aug 9. pii: annrheumdis-2017-211591.
    PubMed     Text format     Abstract available


  176. TAK PP, Doorenspleet ME, de Hair MJH, Klarenbeek PL, et al
    Dominant B cell receptor clones in peripheral blood predict onset of arthritis in individuals at risk for rheumatoid arthritis.
    Ann Rheum Dis. 2017 Aug 8. pii: annrheumdis-2017-211351.
    PubMed     Text format     Abstract available


  177. DE JONG AJ, Klein-Wieringa IR, Kwekkeboom JC, Toes REM, et al
    Inflammatory features of infrapatellar fat pad in rheumatoid arthritis versus osteoarthritis reveal mostly qualitative differences.
    Ann Rheum Dis. 2017 Aug 5. pii: annrheumdis-2017-211673.
    PubMed     Text format    


  178. CAPORALI R, Smolen JS
    Back to the future: forget ultrasound and focus on clinical assessment in rheumatoid arthritis management.
    Ann Rheum Dis. 2017 Aug 2. pii: annrheumdis-2017-211458.
    PubMed     Text format     Abstract available


  179. BAKER KF, Isaacs JD
    Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis?
    Ann Rheum Dis. 2017 Aug 1. pii: annrheumdis-2017-211555.
    PubMed     Text format     Abstract available


  180. TASAKI S, Suzuki K, Nishikawa A, Kassai Y, et al
    Multiomic disease signatures converge to cytotoxic CD8 T cells in primary Sjogren's syndrome.
    Ann Rheum Dis. 2017;76:1458-1466.
    PubMed     Text format     Abstract available


  181. LISNEY AR, Szelinski F, Reiter K, Burmester GR, et al
    High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type I interferon signature is a risk factor for the development of autoimmune congenital heart block.
    Ann Rheum Dis. 2017;76:1476-1480.
    PubMed     Text format     Abstract available


  182. GLINTBORG B, Sorensen IJ, Loft AG, Lindegaard H, et al
    A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry.
    Ann Rheum Dis. 2017;76:1426-1431.
    PubMed     Text format     Abstract available


  183. DEKKERS JS, Verheul MK, Stoop JN, Liu B, et al
    Breach of autoreactive B cell tolerance by post-translationally modified proteins.
    Ann Rheum Dis. 2017;76:1449-1457.
    PubMed     Text format     Abstract available


  184. SCHIEIR O, Tosevski C, Glazier RH, Hogg-Johnson S, et al
    Incident myocardial infarction associated with major types of arthritis in the general population: a systematic review and meta-analysis.
    Ann Rheum Dis. 2017;76:1396-1404.
    PubMed     Text format     Abstract available


  185. MORADI-LAKEH M, Forouzanfar MH, Vollset SE, El Bcheraoui C, et al
    Burden of musculoskeletal disorders in the Eastern Mediterranean Region, 1990-2013: findings from the Global Burden of Disease Study 2013.
    Ann Rheum Dis. 2017;76:1365-1373.
    PubMed     Text format     Abstract available


    July 2017
  186. MICHELSEN B, Kristianslund EK, Sexton J, Hammer HB, et al
    Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study.
    Ann Rheum Dis. 2017 Jul 21. pii: annrheumdis-2017-211284.
    PubMed     Text format     Abstract available


  187. HOLMQVIST M, Ljung L, Askling J
    Acute coronary syndrome in new-onset rheumatoid arthritis: a population-based nationwide cohort study of time trends in risks and excess risks.
    Ann Rheum Dis. 2017 Jul 14. pii: annrheumdis-2016-211066.
    PubMed     Text format     Abstract available


  188. VAN SCHIE KA, Ooijevaar-De Heer P, Kruithof S, Plasencia C, et al
    Infusion reactions during infliximab treatment are not associated with IgE anti-infliximab antibodies.
    Ann Rheum Dis. 2017;76:1285-1288.
    PubMed     Text format     Abstract available


  189. BOUTET MA, Najm A, Bart G, Brion R, et al
    IL-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitro.
    Ann Rheum Dis. 2017;76:1304-1312.
    PubMed     Text format     Abstract available


  190. VAN ZANTEN A, Arends S, Roozendaal C, Limburg PC, et al
    Presence of anticitrullinated protein antibodies in a large population-based cohort from the Netherlands.
    Ann Rheum Dis. 2017;76:1184-1190.
    PubMed     Text format     Abstract available


  191. FISHER BA, Jonsson R, Daniels T, Bombardieri M, et al
    Standardisation of labial salivary gland histopathology in clinical trials in primary Sjogren's syndrome.
    Ann Rheum Dis. 2017;76:1161-1168.
    PubMed     Text format     Abstract available


    June 2017
  192. CHEN YM, Huang WN, Wu YD, Lin CT, et al
    Reactivation of hepatitis B virus infection in patients with rheumatoid arthritis receiving tofacitinib: a real-world study.
    Ann Rheum Dis. 2017 Jun 29. pii: annrheumdis-2017-211322.
    PubMed     Text format    


  193. RUBBERT-ROTH A, Jacobs JWG, Bijlsma JWJ, Welsing PMJ, et al
    A disconnect between disease activity and functional ability already in patients with early rheumatoid arthritis, depending on large joint involvement.
    Ann Rheum Dis. 2017 Jun 23. pii: annrheumdis-2017-211485.
    PubMed     Text format    


  194. SMOLEN JS, Cohen SB, Tony HP, Scheinberg M, et al
    A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritis.
    Ann Rheum Dis. 2017 Jun 21. pii: annrheumdis-2017-211281.
    PubMed     Text format     Abstract available


  195. HYLDGAARD C, Hilberg O, Pedersen AB, Ulrichsen SP, et al
    A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality.
    Ann Rheum Dis. 2017 Jun 13. pii: annrheumdis-2017-211138.
    PubMed     Text format     Abstract available


  196. GLINATSI D, Baker JF, Hetland ML, Horslev-Petersen K, et al
    Magnetic resonance imaging assessed inflammation in the wrist is associated with patient-reported physical impairment, global assessment of disease activity and pain in early rheumatoid arthritis: longitudinal results from two randomised controlled tr
    Ann Rheum Dis. 2017 Jun 13. pii: annrheumdis-2017-211315.
    PubMed     Text format     Abstract available


  197. GEORGE MD, Ostergaard M, Conaghan PG, Emery P, et al
    Obesity and rates of clinical remission and low MRI inflammation in rheumatoid arthritis.
    Ann Rheum Dis. 2017 Jun 12. pii: annrheumdis-2017-211569.
    PubMed     Text format     Abstract available


  198. ARTS EE, Fransen J, Den Broeder AA, van Riel PLCM, et al
    Low disease activity (DAS28</=3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study.
    Ann Rheum Dis. 2017 Jun 12. pii: annrheumdis-2016-210997.
    PubMed     Text format     Abstract available


  199. BOUMAN CA, Herwaarden NV, van den Hoogen FH, Fransen J, et al
    Long-term outcomes after disease activity-guided dose reduction of TNF inhibition in rheumatoid arthritis: 3-year data of the DRESS study - a randomised controlled pragmatic non-inferiority strategy trial.
    Ann Rheum Dis. 2017 Jun 12. pii: annrheumdis-2017-211169.
    PubMed     Text format     Abstract available


  200. BELKHIR R, Burel SL, Dunogeant L, Marabelle A, et al
    Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment.
    Ann Rheum Dis. 2017 Jun 9. pii: annrheumdis-2017-211216.
    PubMed     Text format     Abstract available


  201. HUMPHREYS JH, Costello R, Verstappen SM, Dixon WG, et al
    Response to: Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis by Kremer and Weinblatt.
    Ann Rheum Dis. 2017 Jun 8. pii: annrheumdis-2017-211670.
    PubMed     Text format    


  202. KREMER JM, Weinblatt ME
    Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate.
    Ann Rheum Dis. 2017 Jun 8. pii: annrheumdis-2017-211632.
    PubMed     Text format    


  203. THOMSEN T, Aadahl M, Beyer N, Hetland ML, et al
    The efficacy of motivational counselling and SMS reminders on daily sitting time in patients with rheumatoid arthritis: a randomised controlled trial.
    Ann Rheum Dis. 2017 Jun 5. pii: annrheumdis-2016-210953.
    PubMed     Text format     Abstract available


  204. COHEN S, Genovese MC, Choy E, Perez-Ruiz F, et al
    Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III equivalence study.
    Ann Rheum Dis. 2017 Jun 5. pii: annrheumdis-2016-210459.
    PubMed     Text format     Abstract available


  205. BRITO-ZERON P, Acar-Denizli N, Zeher M, Rasmussen A, et al
    Influence of geolocation and ethnicity on the phenotypic expression of primary Sjogren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjogren Project Consortium.
    Ann Rheum Dis. 2017;76:1042-1050.
    PubMed     Text format     Abstract available


    May 2017
  206. MEISSNER Y, Richter A, Manger B, Tony HP, et al
    Serious adverse events and the risk of stroke in patients with rheumatoid arthritis: results from the German RABBIT cohort.
    Ann Rheum Dis. 2017 May 8. pii: annrheumdis-2017-211209.
    PubMed     Text format     Abstract available


  207. SMOLEN JS, Landewe RBM, van der Heijde D
    Response to: '2016 update of the EULAR recommendations for the management of rheumatoid arthritis: no utopia for patients in low/middle-income countries?' by Misra et al.
    Ann Rheum Dis. 2017 May 6. pii: annrheumdis-2017-211455.
    PubMed     Text format    


  208. BUTTGEREIT F, Bijlsma JW
    Glucocorticoids in rheumatoid arthritis: the picture is shaping up.
    Ann Rheum Dis. 2017 May 4. pii: annrheumdis-2017-211187.
    PubMed     Text format    


  209. PARK JK, Lee MA, Lee EY, Song YW, et al
    Effect of methotrexate discontinuation on efficacy of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial.
    Ann Rheum Dis. 2017 May 3. pii: annrheumdis-2017-211128.
    PubMed     Text format     Abstract available


  210. OGDIE A, Harter L, Shin D, Baker J, et al
    The risk of fracture among patients with psoriatic arthritis and psoriasis: a population-based study.
    Ann Rheum Dis. 2017;76:882-885.
    PubMed     Text format     Abstract available


    April 2017
  211. SAFY M, Jacobs J, IJff ND, Bijlsma J, et al
    Long-term outcome is better when a methotrexate-based treatment strategy is combined with 10 mg prednisone daily: follow-up after the second Computer-Assisted Management in Early Rheumatoid Arthritis trial.
    Ann Rheum Dis. 2017 Apr 27. pii: annrheumdis-2016-210647.
    PubMed     Text format     Abstract available


  212. PIRILA L, Sokka T, Kauppi MJ, Rantalaiho VM, et al
    Alternative interpretation of data for recommendations on how to manage rheumatoid arthritis.
    Ann Rheum Dis. 2017 Apr 27. pii: annrheumdis-2017-211505.
    PubMed     Text format    


  213. CRUZ GI, Shao X, Quach H, Ho KA, et al
    Increased risk of rheumatoid arthritis among mothers with children who carry DRB1 risk-associated alleles.
    Ann Rheum Dis. 2017 Apr 8. doi: 10.1136/annrheumdis-2016-210662.
    PubMed     Text format     Abstract available


  214. BURMESTER GR, Rigby WF, van Vollenhoven RF, Kay J, et al
    Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trial.
    Ann Rheum Dis. 2017 Apr 7. pii: annrheumdis-2016-210561.
    PubMed     Text format     Abstract available


    March 2017
  215. CHATZIDIONYSIOU K, Emamikia S, Nam J, Ramiro S, et al
    Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis.
    Ann Rheum Dis. 2017 Mar 29. pii: annrheumdis-2016-210711.
    PubMed     Text format     Abstract available


  216. MISRA DP, Agarwal V, Sharma A, Wakhlu A, et al
    2016 update of the EULAR recommendations for the management of rheumatoid arthritis: a utopia beyond patients in low/middle income countries?
    Ann Rheum Dis. 2017 Mar 27. pii: annrheumdis-2017-211446.
    PubMed     Text format    


  217. HUMPHREYS JH, Warner A, Costello R, Lunt M, et al
    Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate.
    Ann Rheum Dis. 2017 Mar 23. pii: annrheumdis-2016-210629.
    PubMed     Text format     Abstract available


  218. MANIVEL VA, Mullazehi M, Padyukov L, Westerlind H, et al
    Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up.
    Ann Rheum Dis. 2017 Mar 23. pii: annrheumdis-2016-210873.
    PubMed     Text format     Abstract available


  219. CHARRAS A, Konsta OD, Le Dantec C, Bagacean C, et al
    Cell-specific epigenome-wide DNA methylation profile in long-term cultured minor salivary gland epithelial cells from patients with Sjogren's syndrome.
    Ann Rheum Dis. 2017;76:625-628.
    PubMed     Text format     Abstract available


  220. ROSS EA, Naylor AJ, O'Neil JD, Crowley T, et al
    Treatment of inflammatory arthritis via targeting of tristetraprolin, a master regulator of pro-inflammatory gene expression.
    Ann Rheum Dis. 2017;76:612-619.
    PubMed     Text format     Abstract available


  221. THORARENSEN SM, Lu N, Ogdie A, Gelfand JM, et al
    Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasis.
    Ann Rheum Dis. 2017;76:521-525.
    PubMed     Text format     Abstract available


    February 2017
  222. MAEHARA T, Mattoo H, Ohta M, Mahajan VS, et al
    Lesional CD4+ IFN-gamma+ cytotoxic T lymphocytes in IgG4-related dacryoadenitis and sialoadenitis.
    Ann Rheum Dis. 2017;76:377-385.
    PubMed     Text format     Abstract available


  223. ROSSETTI M, Spreafico R, Consolaro A, Leong JY, et al
    TCR repertoire sequencing identifies synovial Treg cell clonotypes in the bloodstream during active inflammation in human arthritis.
    Ann Rheum Dis. 2017;76:435-441.
    PubMed     Text format     Abstract available


  224. NORDBERG LB, Lillegraven S, Lie E, Aga AB, et al
    Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naive patients classified according to the 2010 ACR/EULAR criteria.
    Ann Rheum Dis. 2017;76:341-345.
    PubMed     Text format     Abstract available


    January 2017
  225. ALAWI KM, Russell FA, Aubdool AA, Srivastava S, et al
    Transient receptor potential canonical 5 (TRPC5) protects against pain and vascular inflammation in arthritis and joint inflammation.
    Ann Rheum Dis. 2017;76:252-260.
    PubMed     Text format     Abstract available


  226. BELL GM, Anderson AE, Diboll J, Reece R, et al
    Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis.
    Ann Rheum Dis. 2017;76:227-234.
    PubMed     Text format     Abstract available


  227. DOUGADOS M, van der Heijde D, Chen YC, Greenwald M, et al
    Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.
    Ann Rheum Dis. 2017;76:88-95.
    PubMed     Text format     Abstract available


  228. SHIBOSKI CH, Shiboski SC, Seror R, Criswell LA, et al
    2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjogren's syndrome: A consensus and data-driven methodology involving three international patient cohorts.
    Ann Rheum Dis. 2017;76:9-16.
    PubMed     Text format     Abstract available


  229. CAPPELLI LC, Gutierrez AK, Baer AN, Albayda J, et al
    Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab.
    Ann Rheum Dis. 2017;76:43-50.
    PubMed     Text format     Abstract available


  230. HENSVOLD AH, Frisell T, Magnusson PK, Holmdahl R, et al
    How well do ACPA discriminate and predict RA in the general population: a study based on 12 590 population-representative Swedish twins.
    Ann Rheum Dis. 2017;76:119-125.
    PubMed     Text format     Abstract available


  231. CHOE JY, Prodanovic N, Niebrzydowski J, Staykov I, et al
    A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy.
    Ann Rheum Dis. 2017;76:58-64.
    PubMed     Text format     Abstract available


  232. EMERY P, Vencovsky J, Sylwestrzak A, Leszczynski P, et al
    A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy.
    Ann Rheum Dis. 2017;76:51-57.
    PubMed     Text format     Abstract available


    October 2016
  233. HUNT L, Hensor EM, Nam J, Burska AN, et al
    T cell subsets: an immunological biomarker to predict progression to clinical arthritis in ACPA-positive individuals.
    Ann Rheum Dis. 2016;75:1884-9.
    PubMed     Text format     Abstract available


  234. VAN HEEMST J, Hensvold AH, Jiang X, van Steenbergen H, et al
    Protective effect of HLA-DRB1*13 alleles during specific phases in the development of ACPA-positive RA.
    Ann Rheum Dis. 2016;75:1891-8.
    PubMed     Text format     Abstract available


  235. CORSIERO E, Bombardieri M, Carlotti E, Pratesi F, et al
    Single cell cloning and recombinant monoclonal antibodies generation from RA synovial B cells reveal frequent targeting of citrullinated histones of NETs.
    Ann Rheum Dis. 2016;75:1866-75.
    PubMed     Text format     Abstract available


  236. VAN STEENBERGEN HW, Mangnus L, Reijnierse M, Huizinga TW, et al
    Clinical factors, anticitrullinated peptide antibodies and MRI-detected subclinical inflammation in relation to progression from clinically suspect arthralgia to arthritis.
    Ann Rheum Dis. 2016;75:1824-30.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: